Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
UNIVERSAL HEALTH INTERNATIONAL GROUP HOLDING LIMITED大健康國際集團控股有限公司
(Incorporated in the Cayman Islands with limited liability)
(Stock Code: 2211) INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2017INTERIM RESULTS HIGHLIGHTS | Six months ended 30 June | |
2017 2016 RMB Million RMB Million | Change | |
(Unaudited) (Unaudited) | (%) | |
Revenue | 1,332.1 1,903.8 | -30.0 |
Gross profit | 274.0 519.8 | -47.3 |
Operating (loss)/profit | (85.6) 115.3 | -174.2 |
(Loss)/profit for the period | (83.5) 87.4 | -195.5 |
EBITDA | (62.1) 138.1 | -145.0 |
Basic (loss)/earnings per share - RMB cents | (3.39) 4.12 | -182.3 |
Gross margin (%) | 20.6 27.3 | -6.7pp |
Operating (loss)/profit margin (%) | (6.4) 6.1 | -12.5pp |
Net (loss)/profit margin (%) | (6.3) 4.6 | -10.9pp |
The board (the "Board") of directors (the "Directors") of Universal Health International Group Holding Limited (the "Company") is pleased to announce the unaudited interim results of the Company and its subsidiaries (collectively, the "Group") for the six months ended 30 June 2017 (the "Period") together with the comparative figures for the corresponding period in 2016 as follows:
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Unaudited) Six months ended 30 JuneNote | 2017 RMB'000 | 2016 RMB'000 | |
Revenue | 2 | 1,332,076 | 1,903,845 |
Cost of sales | 3 | (1,058,102) | (1,384,006) |
Gross profit | 273,974 | 519,839 | |
Selling and marketing expenses | 3 | (315,405) | (360,367) |
Administrative expenses | 3 | (43,901) | (45,374) |
Other income | 892 | 1,668 | |
Other losses - net | (1,162) | (417) | |
Operating (loss)/profit | (85,602) | 115,349 | |
Finance income | 4 | 5,840 | 7,192 |
Finance costs | 4 | (6,919) | (2,721) |
Finance (costs)/income - net | 4 | (1,079) | 4,471 |
Share of post-tax profits of joint ventures | 311 | 441 | |
Share of post-tax profit/(loss) of an associate | 1,580 | (59) | |
(Loss)/profit before income tax | (84,790) | 120,202 | |
Income tax credit/(expenses) | 5 | 1,316 | (32,803) |
(Loss)/profit for the period | (83,474) | 87,399 | |
(Loss)/profit attributable to: - Owners of the Company | (82,109) | 85,837 | |
- Non-controlling interests | (1,365) | 1,562 |
(83,474) | 87,399 | ||
(Loss)/earnings per share attributable to owners of the Company for the period (RMB cents) - Basic and diluted | 6 | (3.39) | 4.12 |
Other comprehensive income/(loss) Item that may be reclassified to profit or loss Currency translation differences | 4,101 | (2,249) | |
Total comprehensive income for the period | (79,373) | 85,150 | |
Total comprehensive income attributable to: - Owners of the Company | (78,008) | 83,588 | |
- Non-controlling interests | (1,365) | 1,562 | |
(79,373) | 85,150 |
CONDENSED CONSOLIDATED BALANCE SHEET | (Unaudited) | (Audited) | |
Note | As at 30 June 2017 RMB'000 | As at 31 December 2016 RMB'000 | |
ASSETS Non-current assets Property, plant and equipment | 224,209 | 226,665 | |
Land use rights | 5,622 | 3,619 | |
Intangible assets | 508,699 | 517,681 | |
Investments in joint ventures | 8,522 | 8,211 | |
Investment in an associate | 248,204 | 246,624 | |
Prepayment for construction in progress | 28,009 | 25,426 | |
Biological assets | 84,800 | - | |
Deferred income tax assets | 12,896 | 12,862 | |
Total non-current assets | 1,120,961 | 1,041,088 | |
Current assets Trade and other receivables | 8 | 522,486 | 545,535 |
Inventories | 357,854 | 391,756 | |
Restricted cash | 208,835 | 217,131 | |
Cash and cash equivalents | 1,003,677 | 1,107,329 | |
Total current assets | 2,092,852 | 2,261,751 | |
Total assets | 3,213,813 | 3,302,839 | |
EQUITY Equity attributable to owners of the Company Share capital | 17,998 | 14,878 | |
Reserves | 1,607,731 | 1,524,900 | |
Retained earnings | 1,086,802 | 1,168,911 | |
2,712,531 | 2,708,689 | ||
Non-controlling interests | 23,396 | 24,761 | |
Total equity | 2,735,927 | 2,733,450 |
As at 31 December
LIABILITIES Non-current liabilities 2017 2016Note RMB'000 RMB'000
Deferred income tax liabilities 38,912 41,282
Current liabilitiesBorrowings | 154,550 | 154,550 | |
Trade and other payables | 9 | 284,183 | 371,926 |
Current income tax liabilities | 241 | 1,631 | |
Total current liabilities | 438,974 | 528,107 | |
Total liabilities | 477,886 | 569,389 | |
Total equity and liabilities | 3,213,813 | 3,302,839 |